IL6 and COVID-19: Patients who are critically ill with COVID-19 are subject to the development of life-threatening acute systemic inflammatory syndromes characterized by multi-organ failure and cytokine-release syndrome (CRS), marked by elevated levels of the proinflammatory cytokine interleukin 6 (IL-6).